Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 601 - 650 out of 11,658

Document Document Title
WO/2010/075026A2
The invention provides drug screening methods and methods for determining efficacy of a therapeutic regimen in humans. In particular, the invention provides screening methods to determine efficacy of a therapeutic regimen to protect huma...  
WO/2010/071941A1
The invention relates to plant extracts and bioactive molecules derived from the plant genus Acronychia and their use as antioxidants, antibacterials, anthelmintic, anti-inflammatories, cancer chemopreventatives, food additives and fragr...  
WO/2010/074220A1
The present invention aims to provide a means for promoting the absorption of sesamins in the body. By using sesamins in combination with epigallocatechin gallate, the absorption of sesamins in the body can be promoted.  
WO/2010/068717A3
The present invention relates to new pyrazolinone scavengers of free radicals, pharmaceutical compositions thereof, and methods of use thereof.  
WO/2010/068717A2
The present invention relates to new pyrazolinone scavengers of free radicals, pharmaceutical compositions thereof, and methods of use thereof.  
WO/2010/063113A1
A method of constructing a VHH library from an immunized camelid, using whole venom or an extract thereof There is also provided VHH antibody fragments isolated from a library produced in hyperimmunized llama These VHH antibody fragments...  
WO/2010/064714A1
Disclosed is a nutrient composition which has an effective prophylactic or ameliorating effect on malnutrition conditions associated with renal diseases, various symptoms such as inflammations, arteriosclerosis, abnormal lipid metabolism...  
WO/2010/062153A1
The present invention relates to a pharmaceutical composition and the method of manufacture thereof, wherein said composition serves to treat internal tissue and organ burns caused by corrosive substances, comprising pharmaceutically acc...  
WO/2010/062205A2
Indication of use of erdosteine as antidote in a large number of intoxications, especially in heavy metals like lead or mercury, and paracetamol. Indication of use of erdosteine as prophylaxis for intoxications. Erdosteine can be adminis...  
WO/2010/061921A1
Disclosed is a method for stabilizing L-ascorbic acid, which is characterized by utilizing a component that naturally occurs in a plant or the like. The method can improve the long-term storage stability of natural L-ascorbic acid conta...  
WO/2010/061412A1
The present invention relates to a new mixture of flours and antioxidants for the preparation of bakery products or for the preparation of fresh or dried alimentary pastas.  
WO/2010/062205A3
Indication of use of erdosteine as antidote in a large number of intoxications, especially in heavy metals like lead or mercury, and paracetamol. Indication of use of erdosteine as prophylaxis for intoxications. Erdosteine can be adminis...  
WO/2010/062205A4
Indication of use of erdosteine as antidote in a large number of intoxications, especially in heavy metals like lead or mercury, and paracetamol. Indication of use of erdosteine as prophylaxis for intoxications. Erdosteine can be adminis...  
WO/2010/062261A1
A method for preparing a controlled release preparation. The method comprises forming a coating mixture, coating a core with the coating mixture for forming a hydrogel layer over the core. The method further comprises coating the hydroge...  
WO/2010/061355A1
This invention is for a compound for treating a human or animal body to relieve the symtons of any one of chemical-, substance-, and medicine induced gastrointestinal tract irritation, the compound including clinoptilolite. The invention...  
WO/2010/059706A2
In certain embodiments this invention pertains to the discovery that inhibition of the expression and/or activity of eukaryotic initiation factor 4A (eIF4A) inhibits the aging process. Accordingly, in certain embodiments, methods are pro...  
WO/2010/058795A1
Provided is an antioxidant which is highly safe, inhibits oxidation of biological components, in particular, lipids and is usable as a drug, a food or a drink, a food additive, an external skin preparation and so on. A compound selected...  
WO/2010/057369A1
Use of photo catalytic nanometer active water is provided in the present invention. The photo catalytic nanometer active water can clean focus of infection of kidney through drinking, injection and targeting administration, and can decom...  
WO/2010/059706A3
In certain embodiments this invention pertains to the discovery that inhibition of the expression and/or activity of eukaryotic initiation factor 4A (eIF4A) inhibits the aging process. Accordingly, in certain embodiments, methods are pro...  
WO/2010/055490A3
The invention relates a phytocomplex obtained from the bergamot fruit albedo (Citrus Bergamia Risso & Poiteau), the production thereof and the use thereof, in particular under the form of dry extract, to be used as normalizer of the meta...  
WO/2010/055490A2
The invention relates a phytocomplex obtained from the bergamot fruit albedo (Citrus Bergamia Risso & Poiteau), the production thereof and the use thereof, in particular under the form of dry extract, to be used as normalizer of the meta...  
WO/2010/055886A1
An aqueous extract is obtained from ashwagandha leaves, which can be collected inexpensively in large quantities, for use as an agent for controlling sensitivity to ultraviolet light. The aqueous extract of ashwagandha leaves acts to pro...  
WO/2010/056754A2
Disclosed are microcapsules that include an inhibitor of the mammalian target of rapamycin (mTOR) within the microcapsules, and pharmaceutical compositions and kits that include the microcapsules. Also disclosed are methods for treating ...  
WO/2010/056754A3
Disclosed are microcapsules that include an inhibitor of the mammalian target of rapamycin (mTOR) within the microcapsules, and pharmaceutical compositions and kits that include the microcapsules. Also disclosed are methods for treating ...  
WO/2010/050794A1
This invention relates to a rich antioxidant nutraceuticals prepared from Nigella sativa seeds for the treatment and prevention of hypercholesterolemia. These nutraceuticals when taken enterally has shown successfully to have hypocholest...  
WO/2010/050794A8
This invention relates to a rich antioxidant nutraceuticals prepared from Nigella sativa seeds for the treatment and prevention of hypercholesterolemia. These nutraceuticals when taken enterally has shown successfully to have hypocholest...  
WO/2010/050178A1
A trehalose compound having high immunopotentiating activity and low toxicity. The trehalose compound is represented by formula (1). (In the formula, X and X' each represents a phenyl, a naphthyl, R1-CHR2- (wherein R1 and R2 each represe...  
WO/2010/048287A2
Provided herein are methods, for reducing, preventing, mitigating and treating damage caused by radiation. The methods comprise delivering a compound, as described herein, to a patient in an amount and dosage regimen effective to prevent...  
WO/2010/048287A9  
WO/2010/045395A3
Novel curcumin-analog compounds are disclosed that are antioxidants useful in inhibition of pro-inflammation, angiogenic, and vascular permeability factors and elimination of reactive oxygen species. The curcumin compounds specifically i...  
WO/2010/045582A3
A method for treating or preventing injury of a biological material exposed to hypoxic or ischemic conditions comprising contacting the biological material with an effective amount of a compound is disclosed. The compound has the followi...  
WO/2010/045582A2
A method for treating or preventing injury of a biological material exposed to hypoxic or ischemic conditions comprising contacting the biological material with an effective amount of a compound is disclosed. The compound has the followi...  
WO/2010/045395A2
Novel curcumin-analog compounds are disclosed that are antioxidants useful in inhibition of pro-inflammation, angiogenic, and vascular permeability factors and elimination of reactive oxygen species. The curcumin compounds specifically i...  
WO/2010/040603A1
The present invention relates to novel dithiolane compounds of formula (I) below: formula (I), in which Y denotes 0, NR1 or S; R1 denotes a hydrogen atom; a saturated linear C1-C20 or branched C3-C20 or unsaturated C2-C20 alkyl hydrocarb...  
WO/2010/037172A1
The invention relates to antioxidant substituted isoindoline nitroxide compounds and their use in methods of treating or preventing diseases or disorders related to oxidative stress, methods of reducing oxidative stress and methods of pr...  
WO/2010/037224A1
Methods for inhibiting cardiomyocyte apoptosis and/or to improving cardiac function and inhibiting inflammation-induced apoptosis in endothelial cells by delivering BRCA1 are provided. Such methods are useful in treatment and prevention ...  
WO/2010/039048A1
The present invention relates to an immunostimulant and to the use of an immunostimulant in the form of a cross-linked muramyl dipeptide microparticle in the treatment of radiation exposure, radiation poisoning, and mitigating the toxic ...  
WO/2010/034118A1
There is provided amino acid ester compounds comprising at least one nitric oxide releasing group, pharmaceutically acceptable salts thereof and compositions thereof. These compounds involve an amino acid side-chain or an amino acid deri...  
WO/2010/035076A1
The present invention belongs to the field of improved personalized medicine. More precisely, the present invention relates to a method for progressively optimizing the 5 -FU dose administered by continuous infusion in patients treated b...  
WO/2010/035806A1
A solid preparation which contains a compound (I) or a salt thereof, a pH adjuster and a calcium antagonist, while having excellent dissolvability and stability.  
WO/2010/032489A1
An iron chelating agent which can selectively chelate iron ions. The iron chelating agent is characterized by being composed of a compound represented by formula (1) or a salt thereof. (In formula (1), ring Z represents an aromatic hyd...  
WO/2010/028503A1
A cysteine-rich undenatured whey-derived protein formulation did not interfere with the tumor-cytotoxic effects of chemotherapy and radiation therapy and did not have a negative effect on the clinical outcome, that is, negatively affect ...  
WO/2010/028596A1
The composition containing ferulic acid and matrine compounds, the use and the preparation thereof. The composition containing ferulic acid and matrine compounds can enhance pharmaceutical effects of both ferulic acid and matrine compoun...  
WO/2010/027488A3
The invention provides heterochimeric antibodies and/or fragments thereof comprising: (i) hypervariable region sequences wholly or substantially corresponding to sequences found in antibodies from a donor species; (ii) constant region se...  
WO/2010/017332A3
Described herein is the discovery that cell and tissue survival can be dramatically increased following radiation exposure through inhibition of the interaction between TSP-1 and CD47. This effect is shown using antisense molecules, pept...  
WO/2010/015827A2
Phosphate binding materials and compositions comprising them which are solid ligand-modif ied poly oxo-hydroxy metal ion materials are disclosed that are based on ferric iron oxo- hydroxides modified with carboxylic acid ligands, or ioni...  
WO/2010/017332A2
Described herein is the discovery that cell and tissue survival can be dramatically increased following radiation exposure through inhibition of the interaction between TSP-1 and CD47. This effect is shown using antisense molecules, pept...  
WO/2010/015827A3
Phosphate binding materials and compositions comprising them which are solid ligand-modif ied poly oxo-hydroxy metal ion materials are disclosed that are based on ferric iron oxo- hydroxides modified with carboxylic acid ligands, or ioni...  
WO/2010/014870A2
Disclosed is a composition for use as an antioxidant, such as for use as an anti-aging supplement. The composition can include a muscadine (Vitis rotundifolid) pomace extract having a polyphenol content of at least 2% and trans- resverat...  
WO/2010/014873A3
Disclosed herein is a method of producing a muscadine pomace extract. The method can include combining a bronze muscadine pomace extract with a purple muscadine pomace extract to produce a muscadine pomace extract, wherein the ratio of b...  

Matches 601 - 650 out of 11,658